Correlation Between Vyne Therapeutics and ENDRA Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and ENDRA Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and ENDRA Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and ENDRA Life Sciences, you can compare the effects of market volatilities on Vyne Therapeutics and ENDRA Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of ENDRA Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and ENDRA Life.

Diversification Opportunities for Vyne Therapeutics and ENDRA Life

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vyne and ENDRA is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and ENDRA Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENDRA Life Sciences and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with ENDRA Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENDRA Life Sciences has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and ENDRA Life go up and down completely randomly.

Pair Corralation between Vyne Therapeutics and ENDRA Life

Given the investment horizon of 90 days Vyne Therapeutics is expected to generate 0.47 times more return on investment than ENDRA Life. However, Vyne Therapeutics is 2.13 times less risky than ENDRA Life. It trades about 0.15 of its potential returns per unit of risk. ENDRA Life Sciences is currently generating about -0.25 per unit of risk. If you would invest  267.00  in Vyne Therapeutics on August 26, 2024 and sell it today you would earn a total of  36.00  from holding Vyne Therapeutics or generate 13.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vyne Therapeutics  vs.  ENDRA Life Sciences

 Performance 
       Timeline  
Vyne Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vyne Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Vyne Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
ENDRA Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ENDRA Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Vyne Therapeutics and ENDRA Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vyne Therapeutics and ENDRA Life

The main advantage of trading using opposite Vyne Therapeutics and ENDRA Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, ENDRA Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENDRA Life will offset losses from the drop in ENDRA Life's long position.
The idea behind Vyne Therapeutics and ENDRA Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios